Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
出版年份 2019 全文链接
标题
Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 10, Pages 2423
出版商
MDPI AG
发表日期
2019-05-16
DOI
10.3390/ijms20102423
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting the c-MET/HGF signaling pathway in pancreatic ductal adenocarcinoma
- (2019) Sadaf Ghanaatgar-Kasbi et al. CURRENT PHARMACEUTICAL DESIGN
- Receptor activity-modifying protein 1 regulates the phenotypic expression of BMSCs via the Hippo/Yap pathway
- (2019) Qin Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ezrin promotes stem cell properties in pancreatic ductal adenocarcinoma
- (2019) Vesselin R Penchev et al. MOLECULAR CANCER RESEARCH
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity
- (2018) Shiue-Wei Lai et al. CLINICAL & EXPERIMENTAL METASTASIS
- KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer
- (2018) Kege Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years
- (2018) Bradley R. Hall et al. Oncotarget
- PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma
- (2018) Ann E. Zeleniak et al. NEOPLASIA
- Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α
- (2018) Bin Yan et al. EXPERIMENTAL CELL RESEARCH
- PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis
- (2018) Peipei Wang et al. Oncotarget
- Verteporfin as a Medical Treatment in Peyronie’s Disease
- (2018) Daan C.J. Mohede et al. Sexual Medicine
- Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer
- (2018) Courtney M Schaal et al. Molecular Cancer
- Neoadjuvant Treatment for Pancreatic Cancer
- (2018) Alexander G. Raufi et al. SEMINARS IN ONCOLOGY
- Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
- (2018) Naiara Santana-Codina et al. Nature Communications
- RalB directly triggers invasion downstream Ras by mobilizing the Wave complex
- (2018) Giulia Zago et al. eLife
- Sphingomyelin Metabolism Is a Regulator of K-Ras Function
- (2017) Dharini van der Hoeven et al. MOLECULAR AND CELLULAR BIOLOGY
- Pancreatic Cancer Chemoresistance to Gemcitabine
- (2017) Manoj Amrutkar et al. Cancers
- YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling
- (2016) Ralph Gruber et al. GASTROENTEROLOGY
- Concepts to Target MYC in Pancreatic Cancer
- (2016) M. Wirth et al. MOLECULAR CANCER THERAPEUTICS
- Management of Metastatic Pancreatic Adenocarcinoma
- (2016) Ahmad R. Cheema et al. SURGICAL CLINICS OF NORTH AMERICA
- FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
- (2015) Eran Sadot et al. ANNALS OF SURGICAL ONCOLOGY
- Activation of pancreatic stellate cells involves an EMT-like process
- (2015) LEI TIAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer
- (2015) Sara M. Tolaney et al. INVESTIGATIONAL NEW DRUGS
- Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Giorgio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma
- (2015) Qingfeng Xiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas
- (2015) R. Nussinov et al. MOLECULAR CANCER RESEARCH
- MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies
- (2015) E Hessmann et al. ONCOGENE
- YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells
- (2015) Namrata Bora-Singhal et al. STEM CELLS
- Update on the management of pancreatic cancer: Surgery is not enough
- (2015) Daniel Ansari et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling
- (2015) Neha Woods et al. Oncotarget
- Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3
- (2015) Shuping Yang et al. Oncotarget
- Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer
- (2015) Namrata Bora-Singhal et al. NEOPLASIA
- Genomic alterations in pancreatic cancer and their relevance to therapy
- (2015) Erina Takai et al. World Journal of Gastrointestinal Oncology
- Nicotine Induces Inhibitor of Differentiation-1 in a Src-dependent Pathway Promoting Metastasis and Chemoresistance in Pancreatic Adenocarcinoma
- (2015) Jose G. Trevino et al. NEOPLASIA
- A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
- (2014) S. Pant et al. ANNALS OF ONCOLOGY
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
- (2014) Avnish Kapoor et al. CELL
- The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
- (2014) X. Varelas DEVELOPMENT
- VEGF and Id-1 in pancreatic adenocarcinoma: Prognostic significance and impact on angiogenesis
- (2014) D. Georgiadou et al. EJSO
- The Hippo signaling pathway in stem cell biology and cancer
- (2014) J.-S. Mo et al. EMBO REPORTS
- Fascin Is Regulated by Slug, Promotes Progression of Pancreatic Cancer in Mice, and Is Associated With Patient Outcomes
- (2014) Ang Li et al. GASTROENTEROLOGY
- Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK.
- (2014) BC Reeves et al. HEALTH TECHNOLOGY ASSESSMENT
- YAP activation is an early event and a potential therapeutic target in liver cancer development
- (2014) Andrea Perra et al. JOURNAL OF HEPATOLOGY
- Tivantinib (ARQ 197) Exhibits Antitumor Activity by Directly Interacting with Tubulin and Overcomes ABC Transporter-Mediated Drug Resistance
- (2014) A. Aoyama et al. MOLECULAR CANCER THERAPEUTICS
- Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines
- (2014) Antonio Calles et al. Molecular Oncology
- Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
- (2014) W. Zhang et al. Science Signaling
- GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells
- (2013) Lily L. Remsing Rix et al. ACS Chemical Biology
- Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
- (2013) R. Katayama et al. CANCER RESEARCH
- Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET
- (2013) C. Basilico et al. CLINICAL CANCER RESEARCH
- The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development
- (2013) Evan R Barry et al. CURRENT OPINION IN CELL BIOLOGY
- Inhibition of Amyloid Precursor Protein Processing Enhances Gemcitabine-mediated Cytotoxicity in Pancreatic Cancer Cells
- (2013) Neha Kabra Woods et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Snail Cooperates with KrasG12D to Promote Pancreatic Fibrosis
- (2013) M. A. Shields et al. MOLECULAR CANCER RESEARCH
- KRas Induces a Src/PEAK1/ErbB2 Kinase Amplification Loop That Drives Metastatic Growth and Therapy Resistance in Pancreatic Cancer
- (2012) J. A. Kelber et al. CANCER RESEARCH
- Src-mediated regulation of E-cadherin and EMT in pancreatic cancer
- (2012) Nagaraj et al. Frontiers in Bioscience-Landmark
- Nestin and other putative cancer stem cell markers in pancreatic cancer
- (2012) Yoko Matsuda et al. Medical Molecular Morphology
- The RalB Small GTPase Mediates Formation of Invadopodia through a GTPase-Activating Protein-Independent Function of the RalBP1/RLIP76 Effector
- (2012) N. F. Neel et al. MOLECULAR AND CELLULAR BIOLOGY
- Fendiline Inhibits K-Ras Plasma Membrane Localization and Blocks K-Ras Signal Transmission
- (2012) D. van der Hoeven et al. MOLECULAR AND CELLULAR BIOLOGY
- Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway
- (2012) L Adesso et al. ONCOGENE
- The Hippo signaling pathway and stem cell biology
- (2012) Azucena Ramos et al. TRENDS IN CELL BIOLOGY
- ARRB1-Mediated Regulation of E2F Target Genes in Nicotine-Induced Growth of Lung Tumors
- (2011) Piyali Dasgupta et al. JNCI-Journal of the National Cancer Institute
- c-MET as a potential therapeutic target and biomarker in cancer
- (2011) J. Rafael Sierra et al. Therapeutic Advances in Medical Oncology
- Phenotype and Genotype of Pancreatic Cancer Cell Lines
- (2010) Emily L. Deer et al. PANCREAS
- Id1/Id3 Knockdown Inhibits Metastatic Potential of Pancreatic Cancer
- (2008) Yasutaka Shuno et al. JOURNAL OF SURGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search